Stocks to Watch Today (April 20, 2026): HDFC Bank, ICICI Bank, MCX, Cipla, Lupin, TCS and more

Indian markets are likely to remain stock-specific on Monday as earnings, regulatory updates, and corporate actions drive sentiment. An Indian delegation’s US visit for trade talks will also be tracked by investors.

HDFC Bank

• Q4FY26 performance came largely in line with estimates
• NII rose 3 per cent YoY to ~Rs 33,082 crore
• Net profit increased 9 per cent YoY to ~Rs 19,221 crore
• Provisions declined 18 per cent YoY, supporting earnings
• Asset quality improved. GNPA stood at 1.15 per cent. NNPA at 0.38 per cent
• Deposits grew 12.8 per cent. Advances rose 12 per cent
• Retail loan growth remained moderate at 6.5 per cent
• SME loans saw strong growth of 17.2 per cent
• Management indicated support for Keki Mistry as board chairman

Add Zee Business as a Preferred Source

ICICI Bank

• Delivered strong Q4 results and beat expectations
• NII increased 8.4 per cent YoY to ~Rs 22,979 crore
• Net profit rose 8.4 per cent YoY to ~Rs 13,701 crore
• Sharp fall in provisions by 89 per cent YoY boosted profitability
• Asset quality improved. GNPA at 1.4 per cent. NNPA at 0.3 per cent
• Advances grew 15.8 per cent, showing strong credit demand
• Deposits rose 11.4 per cent, maintaining healthy growth

Jio Financial Services

• Announced a key management change
• CFO Abhishek Haridas Pathak resigned
• Annapoorna Venkataramanan appointed as new Group CFO
• Change comes as the company expands its financial services business

Aditya Birla Money

• Reported mixed performance
• Revenue rose 21.7 per cent YoY
• EBITDA declined 28 per cent due to cost pressures
• Margins contracted
• Net profit more than doubled, supported by other income

Mastek

• Reported mixed sequential numbers
• Revenue grew 4 per cent QoQ
• EBIT and margins saw slight decline
• Net profit also edged lower
• Announced final dividend of ~Rs 16 per share

Cipla

• USFDA inspected Goa manufacturing facility
• Inspection held between April 6 and 17
• 2 observations issued under Form 483
• Investors will track corrective actions

Lupin

• USFDA inspection at Somerset, New Jersey plant
• Conducted between April 13 and 17
• 3 observations issued under Form 483
• Compliance updates remain key monitorable

Aurobindo Pharma

• Received final USFDA approval for key product
• Approval for Dextromethorphan Polistirex oral suspension
• Launch expected in Q2FY27
• Will strengthen US portfolio

Dredging Corporation of India

• Signed Rs 2,157 crore MoU with Indian Oil Corporation
• Agreement valid for 5 years
• Ensures stable fuel supply for operations
• Supports long-term project execution

Zee Entertainment Enterprises

• Approved investment up to Rs 116 crore
• Investment in Phantom Digital Effects via CCDs
• Focus on improving VFX capabilities
• Aims to strengthen OTT and film content pipeline

Multi Commodity Exchange

• Received approval from Securities and Exchange Board of India
• Will set up coal exchange subsidiary
• Strategic move to expand product offerings

Shyam Metalics and Energy

• Enforcement Directorate attached assets worth ~Rs 159.5 crore
• Linked to subsidiary transactions
• Company clarified impact is limited
• Legal proceedings are ongoing

EMS Limited

• Emerged as L1 bidder for sewer infrastructure projects
• Orders from UP Jal Nigam
• Total order value ~Rs 208 crore
• Includes design, construction and network development

Tata Consultancy Services

• Initial internal probe found no wrongdoing
• Investigation continues under senior leadership
• External agencies also involved in review

Other stocks in focus

• Lemon Tree Hotels: Signed license for new 90-room hotel in Gujarat. Expanding footprint.
• Ola Electric: Launched festive offers under ‘Ola Sona Weekend’. Demand push expected.
• Neogen Chemicals: Raised Rs 161 crore via preferential allotment to promoters.
• Ratnaveer Precision Engineering: Board to consider fundraising up to Rs 300 crore.